168 related articles for article (PubMed ID: 34298765)
1. Claisened Hexafluoro Inhibits Metastatic Spreading of Amoeboid Melanoma Cells.
Leo A; Pranzini E; Pietrovito L; Pardella E; Parri M; Cirri P; Bruno G; Calvani M; Peppicelli S; Torre E; Sasaki M; Yang L; Zhu L; Chiarugi P; Raugei G; Arbiser JL; Taddei ML
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298765
[TBL] [Abstract][Full Text] [Related]
2. ShcD Binds DOCK4, Promotes Ameboid Motility and Metastasis Dissemination, Predicting Poor Prognosis in Melanoma.
Aladowicz E; Granieri L; Marocchi F; Punzi S; Giardina G; Ferrucci PF; Mazzarol G; Capra M; Viale G; Confalonieri S; Gandini S; Lotti F; Lanfrancone L
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33202906
[TBL] [Abstract][Full Text] [Related]
3. Zoledronic Acid Inhibits the RhoA-mediated Amoeboid Motility of Prostate Cancer Cells.
Pietrovito L; Comito G; Parri M; Giannoni E; Chiarugi P; Taddei ML
Curr Cancer Drug Targets; 2019; 19(10):807-816. PubMed ID: 30648509
[TBL] [Abstract][Full Text] [Related]
4. Podoplanin drives dedifferentiation and amoeboid invasion of melanoma.
de Winde CM; George SL; Crosas-Molist E; Hari-Gupta Y; Arp AB; Benjamin AC; Millward LJ; Makris S; Carver A; Imperatore V; Martínez VG; Sanz-Moreno V; Acton SE
iScience; 2021 Sep; 24(9):102976. PubMed ID: 34485858
[TBL] [Abstract][Full Text] [Related]
5. EphA2 induces metastatic growth regulating amoeboid motility and clonogenic potential in prostate carcinoma cells.
Taddei ML; Parri M; Angelucci A; Bianchini F; Marconi C; Giannoni E; Raugei G; Bologna M; Calorini L; Chiarugi P
Mol Cancer Res; 2011 Feb; 9(2):149-60. PubMed ID: 21205836
[TBL] [Abstract][Full Text] [Related]
6. Sustained Inflammatory Signalling through Stat1/Stat2/IRF9 Is Associated with Amoeboid Phenotype of Melanoma Cells.
Gandalovičová A; Šůchová AM; Čermák V; Merta L; Rösel D; Brábek J
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32872349
[TBL] [Abstract][Full Text] [Related]
7. β-catenin inhibitor ICAT modulates the invasive motility of melanoma cells.
Domingues MJ; Rambow F; Job B; Papon L; Liu W; Larue L; Bonaventure J
Cancer Res; 2014 Apr; 74(7):1983-95. PubMed ID: 24514042
[TBL] [Abstract][Full Text] [Related]
8. PKCα promotes the mesenchymal to amoeboid transition and increases cancer cell invasiveness.
Vaškovičová K; Szabadosová E; Čermák V; Gandalovičová A; Kasalová L; Rösel D; Brábek J
BMC Cancer; 2015 Apr; 15():326. PubMed ID: 25924946
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia Induces a HIF-1-Dependent Transition from Collective-to-Amoeboid Dissemination in Epithelial Cancer Cells.
Lehmann S; Te Boekhorst V; Odenthal J; Bianchi R; van Helvert S; Ikenberg K; Ilina O; Stoma S; Xandry J; Jiang L; Grenman R; Rudin M; Friedl P
Curr Biol; 2017 Feb; 27(3):392-400. PubMed ID: 28089517
[TBL] [Abstract][Full Text] [Related]
10. Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma.
Shinada M; Kato D; Motegi T; Tsuboi M; Ikeda N; Aoki S; Iguchi T; Li T; Kodera Y; Ota R; Hashimoto Y; Takahashi Y; Chambers J; Uchida K; Kato Y; Nishimura R; Nakagawa T
Mol Cancer Res; 2023 Nov; 21(11):1205-1219. PubMed ID: 37493578
[TBL] [Abstract][Full Text] [Related]
11. Transition from mesenchymal to bleb-based motility is predominantly exhibited by CD133-positive subpopulation of fibrosarcoma cells.
Chikina AS; Rubtsova SN; Lomakina ME; Potashnikova DM; Vorobjev IA; Alexandrova AY
Biol Cell; 2019 Oct; 111(10):245-261. PubMed ID: 31403697
[TBL] [Abstract][Full Text] [Related]
12. Dual Targeting of Mesenchymal and Amoeboid Motility Hinders Metastatic Behavior.
Jones BC; Kelley LC; Loskutov YV; Marinak KM; Kozyreva VK; Smolkin MB; Pugacheva EN
Mol Cancer Res; 2017 Jun; 15(6):670-682. PubMed ID: 28235899
[TBL] [Abstract][Full Text] [Related]
13. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.
Yamazaki D; Kurisu S; Takenawa T
Oncogene; 2009 Apr; 28(13):1570-83. PubMed ID: 19234490
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor promotes a mesenchymal over an amoeboid motility of MDA-MB-231 cells embedded within a 3D collagen matrix
Geum DT; Kim BJ; Chang AE; Hall MS; Wu M
Eur Phys J Plus; 2016 Jan; 131(1):. PubMed ID: 31367506
[TBL] [Abstract][Full Text] [Related]
15. Apolar and polar transitions drive the conversion between amoeboid and mesenchymal shapes in melanoma cells.
Cooper S; Sadok A; Bousgouni V; Bakal C
Mol Biol Cell; 2015 Nov; 26(22):4163-70. PubMed ID: 26310441
[TBL] [Abstract][Full Text] [Related]
16. Plasticity of cancer cell invasion: Patterns and mechanisms.
Wu JS; Jiang J; Chen BJ; Wang K; Tang YL; Liang XH
Transl Oncol; 2021 Jan; 14(1):100899. PubMed ID: 33080522
[TBL] [Abstract][Full Text] [Related]
17. EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style.
Parri M; Taddei ML; Bianchini F; Calorini L; Chiarugi P
Cancer Res; 2009 Mar; 69(5):2072-81. PubMed ID: 19244130
[TBL] [Abstract][Full Text] [Related]
18. Localized translation regulates cell adhesion and transendothelial migration.
Bergeman J; Caillier A; Houle F; Gagné LM; Huot MÉ
J Cell Sci; 2016 Nov; 129(21):4105-4117. PubMed ID: 27637266
[TBL] [Abstract][Full Text] [Related]
19. The actin-associating protein Tm5NM1 blocks mesenchymal motility without transition to amoeboid motility.
Lees JG; Bach CT; Bradbury P; Paul A; Gunning PW; O'Neill GM
Oncogene; 2011 Mar; 30(10):1241-51. PubMed ID: 21076470
[TBL] [Abstract][Full Text] [Related]
20. Increased Level of Long Non-Coding RNA MALAT1 is a Common Feature of Amoeboid Invasion.
Merta L; Gandalovičová A; Čermák V; Dibus M; Gutschner T; Diederichs S; Rösel D; Brábek J
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32369931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
